Potent corticosteroid + antibacterial
Betamethasone with fusidic acid
Brand names: Fucibet
Adult dose
Dose: Apply BD
Route: Topical
Frequency: BD ≤7 days
Clinical pearls
- NICE NG198 eczema with bacterial component: short course
- BAD antibiotic stewardship — do NOT use ≥7 days
- Resistance to fusidic acid in S. aureus prevalent
Contraindications
- Untreated viral / fungal infection
- Hypersensitivity
Side effects
- Skin atrophy
- Telangiectasia
- Folliculitis
- Antibiotic resistance (limit duration)
Monitoring
- Skin response
- Treatment duration
Reference: BNF; NICE NG198; BAD; https://bnf.nice.org.uk/drugs/betamethasone-with-fusidic-acid/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD